Following regulatory approval of Alison Platt, the Board of Hargreaves Lansdown announces her appointment as Chair of the Board and Non-Executive Director of HL with effect from 6 February 2024.
Alison Platt has extensive leadership experience in both private and public companies in the healthcare, financial services, retail and property and regulated sectors. He currently holds chairmanships at Dechra Pharmaceuticals, a FTSE100 specialist veterinary products business and at Ageas UK insurer. She has also been a Non-Executive Director of Tesco Plc since 2016.
Ms Platt was Managing Director of Countrywide from 2014 to 2018 and previously held a number of senior roles at BUPA, including Managing Director of the International Development Markets business. She was previously non-executive director of the Foreign and Commonwealth Office, a member of the Hampton-Alexander review steering group advising on diversity and inclusion, and chair of Opportunity Now.